课题基金 / 基金详情

项目摘要

项目成果

XINBIN GU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Head and neck cancer is the sixth most common cancer worldwide, the seventh most common solid tumor in the United States. The incidence of head and neck cancer in African American men has been approximately two times higher than that of non African American men with a lower 5-year relative survival (36.2% vs. 47.6%). Howard University Medical Institutions is a minority-serving educational institution and medical center that is an important educational and clinical resource in the Washington DC/ Baltimore metropolitan area and serves a large community of low-income African American patients. However, recruitment and support for translational research efforts at Howard University has significant challenges. The goal of this proposal is to create a collaborative environment to enhance translational research and education related to head and neck cancer at the Howard University Medical Institutions through a highly collaborative effort between the Howard University Medical Institutions and the Head and Neck Cancer Center at the Johns Hopkins Medical Institutions. This collaboration is focused on translational research and research training as well as educational efforts focused on enhancing head and neck cancer translational research and impact on the Howard Medical Institutions community. Specific aims will be: 1) to support collaborative cancer research projects between the Howard University Medical Institutions and the Head and Neck Cancer Center and Sidney Kimmel Cancer Center at Johns Hopkins 2) to provide collaborative training and mentoring program for promoting Howard medical and dental students and faculty in cancer research, 3) to establish education programs that advance the knowledge of translational cancer research as it applies to etiology, prevention, diagnosis, and treatment of head and neck cancer in the context of minority-serving institutions. These aims will be promoted and coordinated in a synergistic manner, such that they reinforce the creation of a culture of collaborative translational research within the Howard University Cancer Center as well as an effective long-term partnership with investigators at the Johns Hopkins Medical Institutions. These goals will be pursued by directed mentorship of individuals at Howard Medical Institutions to develop as independent investigators via traditional mechanisms of the National Cancer Institute.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.
Salvianolic Acid B,一种潜在的化学预防剂,用于头颈鳞状细胞癌。
DOI: 10.1155/2011/534548
发表时间: 2011
期刊: Journal of oncology
影响因子: --
作者: [Zhao Y, Guo Y, Gu X]
通讯作者: Gu X
[Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector].
含2A片段的重组黄热病病毒17D作为疫苗载体的构建
DOI: --
发表时间: 2006
期刊: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
影响因子: --
作者: [Xiaowu,Pang, Fu,Wen-Chuan, Guo,Yin-Han, Zhang,Li-Shu, Xie,Tian-Pei, Xinbin,Gu]
通讯作者: Xinbin,Gu
[Anticancer mechanisms of vitamin E succinate].
维生素E琥珀酸酯的抗癌机制[J].
DOI: 10.5732/cjc.008.10182
发表时间: 2009
期刊: Ai zheng = Aizheng = Chinese journal of cancer
影响因子: --
作者: [Dong,Yong-Heng, Guo,Yin-Han, Gu,Xin-Bin]
通讯作者: Gu,Xin-Bin
Howard University Summer Research Education Experience Program in Oral Health
  • 批准号:
    10594263
  • 项目类别:
  • 资助金额:
    $13.38万
  • 财政年份:
    2023
  • 负责人:
    XINBIN GU
  • 依托单位:
Howard University Summer Research Experience Program in Oral Health Disparity for Underrepresented Racial and Ethnic Students
  • 批准号:
    9198985
  • 项目类别:
  • 资助金额:
    $5.28万
  • 财政年份:
    2016
  • 负责人:
    XINBIN GU
  • 依托单位:
HU/JHU Head and Neck Cancer Translational Research and *
  • 批准号:
    7281578
  • 项目类别:
  • 资助金额:
    $18.96万
  • 财政年份:
    2005
  • 负责人:
    XINBIN GU
  • 依托单位:
HU/JHU Head and Neck Cancer Translational Research and *
  • 批准号:
    7026841
  • 项目类别:
  • 资助金额:
    $22.2万
  • 财政年份:
    2005
  • 负责人:
    XINBIN GU
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: